SCHEMBL8520672

SCHEMBL8520672

Cc1c(SCCCN2CCN(c3ncccn3)CC2)ccnc1CSc1nc2ccccc2[nH]1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.49
CYP1A2 P05177 2/20 0.49
CYP2D6 P10635 2/20 0.49
CYP2C9 P11712 2/20 0.49
CYP2C19 P33261 2/20 0.49
NPC1 O15118 2/20 0.49
CYP3A4 P08684 1/20 0.49
DRD2 P14416 3/20 0.48
DRD3 P35462 3/20 0.48
GRIN2A Q12879 1/20 0.47
GRIN2B Q13224 1/20 0.47
GRIN2C Q14957 1/20 0.47
DRD4 P21917 1/20 0.47
HTR1A P08908 1/20 0.44
DRD1 P21728 1/20 0.44
DRD5 P21918 1/20 0.44
HTR2A P28223 1/20 0.44
CYP2E1 P05181 1/20 0.43
CYP2C8 P10632 1/20 0.43
CYP2B6 P20813 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8520779 0.92 DRD4 (0.51) RAB9ACYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL8916879 0.89 RAB9A (0.60) RAB9ACYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL8915325 0.84 RAB9A (0.55) RAB9ACYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL8412992 0.84 NPC1 (0.60) RAB9ACYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL8812118 0.84 RAB9A (0.44) RAB9ACYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL8915135 0.84 RAB9A (0.54) RAB9ACYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL8915606 0.84 RAB9A (0.69) RAB9ACYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL7812118 0.82 NPC1 (0.56) RAB9ACYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL7807341 0.82 NPC1 (0.58) RAB9ACYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL8914004 0.82 NPC1 (0.58) RAB9ACYP1A2CYP2D6CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5922720-A PHARMACEUTICAL FOR USE IN TREATMENT OF DISEASES BASED ON HELICOBACTER BACTERIA BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) 1999-07-13 US disclosed